吴汉靓2020-05-13 23:21
之前写过一些ppar激动剂,发现昨天晚上真是上演了悲喜剧:Genfit的ppar在NASH领域的III期未达临床终点;Cymabay的ppar又重燃在NASH的希望
$Genfit(GNFT)$ $Cymabay Therapeutics(CBAY)$查看全文
chuminhua2020-05-12 11:06
5/11,Genfit公司$Genfit(GNFT)$ 宣布其PPARα和PPARδ的双重激动剂elafibranor在治疗非酒精性脂肪性肝炎(NASH)的III期RESOLVE-IT 研究中,治疗第72周的结果显示,elafibranor 治疗组和安慰剂组NASH组织学改善且肝脏纤维化没有恶化的患者比例分别为19.2% 和14.7%,纤维化程度至少改善一级的患者...查看全文
医药魔方2020-05-12 10:41
5月11日,Genfit公司宣布其elafibranor在治疗非酒精性脂肪性肝炎(NASH)的III期RESOLVE-IT 研究中,较安慰剂未能显著改善患者NASH组织学症状和不加剧肝脏纤维化,错过主要终点。
该研究共纳入1070例NASH患者,患者随机(2:1)接受elafibranor 120mg/天和安慰剂的治疗。治疗第72周的结果显示,...查看全文
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003861 Act: 34 Size: 254 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003476 Act: 34 Size: 95 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003373 Act: 34 Size: 108 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003152 Act: 34 Size: 90 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-003049 Act: 34 Size: 67 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-002860 Act: 34 Size: 85 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-002242 Act: 34 Size: 82 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-002021 Act: 34 Size: 253 KB 网页链接
$Genfit(GNFT)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-24-001868 Act: 34 Size: 58 KB 网页链接
$Genfit(GNFT)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001757064-24-000007 Act: 34 Size: 40 MB 网页链接